1. Home
  2. BLRX vs MESA Comparison

BLRX vs MESA Comparison

Compare BLRX & MESA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLRX
  • MESA
  • Stock Information
  • Founded
  • BLRX 2003
  • MESA 1982
  • Country
  • BLRX Israel
  • MESA United States
  • Employees
  • BLRX N/A
  • MESA N/A
  • Industry
  • BLRX Biotechnology: Pharmaceutical Preparations
  • MESA Air Freight/Delivery Services
  • Sector
  • BLRX Health Care
  • MESA Consumer Discretionary
  • Exchange
  • BLRX Nasdaq
  • MESA Nasdaq
  • Market Cap
  • BLRX 36.0M
  • MESA 48.7M
  • IPO Year
  • BLRX 2011
  • MESA 2018
  • Fundamental
  • Price
  • BLRX $0.20
  • MESA $1.13
  • Analyst Decision
  • BLRX Strong Buy
  • MESA
  • Analyst Count
  • BLRX 2
  • MESA 0
  • Target Price
  • BLRX $5.50
  • MESA N/A
  • AVG Volume (30 Days)
  • BLRX 1.7M
  • MESA 258.4K
  • Earning Date
  • BLRX 11-25-2024
  • MESA 12-31-2024
  • Dividend Yield
  • BLRX N/A
  • MESA N/A
  • EPS Growth
  • BLRX N/A
  • MESA N/A
  • EPS
  • BLRX N/A
  • MESA N/A
  • Revenue
  • BLRX $21,991,000.00
  • MESA $475,518,000.00
  • Revenue This Year
  • BLRX N/A
  • MESA $15.09
  • Revenue Next Year
  • BLRX N/A
  • MESA $16.19
  • P/E Ratio
  • BLRX N/A
  • MESA N/A
  • Revenue Growth
  • BLRX N/A
  • MESA N/A
  • 52 Week Low
  • BLRX $0.19
  • MESA $0.55
  • 52 Week High
  • BLRX $1.68
  • MESA $1.89
  • Technical
  • Relative Strength Index (RSI)
  • BLRX 25.94
  • MESA 59.01
  • Support Level
  • BLRX $0.23
  • MESA $1.04
  • Resistance Level
  • BLRX $0.56
  • MESA $1.20
  • Average True Range (ATR)
  • BLRX 0.03
  • MESA 0.08
  • MACD
  • BLRX 0.00
  • MESA 0.01
  • Stochastic Oscillator
  • BLRX 11.82
  • MESA 66.67

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

About MESA Mesa Air Group Inc.

Mesa Air Group Inc is a regional air carrier providing scheduled passenger service. It provides scheduled passenger service to 86 cities in 36 states, the District of Columbia, Canada, Cuba, and Mexico as well as cargo services out of Cincinnati/Northern Kentucky International Airport. Flights are operated as American Eagle, United Express, or DHL Express flights to the terms of capacity purchase agreements with American and United and a flight services agreement with DHL. The business has a presence in domestic hubs and cities, including Dallas, Houston, Phoenix, and Washington-Dulles and other regions.

Share on Social Networks: